Biotech, Food & Drug

HB Ad Slot
HB Mobile Ad Slot

In today’s hyper-aware environment, concerns about food and drug safety are paramount for both companies and consumers.  The Food and Drug Administration (FDA) and the US Department of Agriculture (USDA) regulates the areas of biotech, food, and drug law. Additionally, laws including the 21st Century Cures Act, and cGMP (Current Good Manufacturing Processes), regulate industry standards/norms in food, cosmetics, and other industry-sectors. Visitors to the National Law Review will find the latest analysis of news, legislation, and upcoming cases/litigation as it relates to this area of law.

With researchers searching for new energy solutions and other developments in biotech, visitors to the NLR will have the opportunity to read content surrounding biosimilars, natural fuel production, medical devices, biotechnology, nanotechnology and materials, and the pharmaceuticals industry. Additionally, content relating to food and drug laws, limits on chemical use in cosmetic products, and other general health/safety topics are covered by the National Law Review and are updated regularly. Additionally, food safety and imports to the United States are also discussed as they become relevant. 

In addition to general health, science, and food/drug, the industry is also closely related to many of the issues related to intellectual property law. New applications for patents, intellectual property, licensing laws, and other areas which are governed by the PTAB court, often crossover into the industry.

New developments in legislation, including the legalization of recreational marijuana has created a new area ripe for legal analysis.  Regulations on how recreational marijuana can be advertised and marketed, distributed and the kind of insurance coverage necessary for dispensaries.  Additionally, employer drug-testing and marijuana statutes have been a hot area of litigation covered by the National Law Review.  

General practices in marketing standards, compliance of federal and state laws/legislation, licensing collaborations, and news related to bringing new products to the market, in the US and abroad, are among the areas visitors to NLR will read about daily. Drug pricing, changes in production standards, regulatory compliance, food safety and handling, drug laws (legalization of marijuana, both recreational and medicinal in the workplace), and labeling and nutritional requirements, are among the many topics covered by the National Law Review daily.

Visitors will always find the latest, up-to-date, most comprehensive coverage on the site. And, news and stories which affect the US, companies which are regulated in the industry, and multinational/international companies, are detailed regularly for NLR readers.

National Law Review Cannabis TwitterFor hourly updates on the latest news about biotech, food & drug, and cannabis laws, regulations, and legislation, be sure to follow our Cannabis X (formerly Twitter) feed, and sign up for complimentary e-news bulletins.

Recent Biotechnology, Food & Drug Administration FDA News

Title
Publication Date Organization
Jun
1
2024
Breaking Down Federal Policies to Address Drug Shortages McDermott Will & Emery
May
31
2024
FDA Gets Technical on HCT/P Rules in Warning Letter to Human Tissue Company Sheppard, Mullin, Richter & Hampton LLP
May
31
2024
This Week in 340B: May 21 – May 27, 2024 McDermott Will & Emery
May
31
2024
DOJ Proposes to Reschedule Marijuana (Cannabis) To Schedule III McDermott Will & Emery
May
30
2024
Louisiana Becomes First State to Classify Mifepristone and Misoprostol as Controlled Substances Epstein Becker & Green, P.C.
May
30
2024
Pasta False Ad Class Action Receives Certification Keller and Heckman LLP
May
30
2024
Labor Law Update: Union Certification Without Winning the Employee Vote McDermott Will & Emery
May
30
2024
Sour Grapes: Winery Minority Ownership Insufficient for Statutory Standing at Trademark Board McDermott Will & Emery
May
30
2024
The Beginning of the End of Service Charges? An Examination of California’s SB 478 Ogletree, Deakins, Nash, Smoak & Stewart, P.C.
May
29
2024
USDA Requests Information on Electronic or Digital Link Bioengineered Disclosure Options Keller and Heckman LLP
May
29
2024
Rescheduling Madness: Key Takeaways from the Proposed Rule to Reschedule Marijuana under the CSA Mintz
May
29
2024
FDA Establishes CDER Center for Clinical Trial Innovation (C3TI) McDermott Will & Emery
May
28
2024
Indiana Judge Rules Tacos and Burritos are “Sandwiches” Keller and Heckman LLP
May
28
2024
Nuts or Not Nuts? Second Circuit Declines to Consider Whether KIND’s Use of All-Natural Is Deceptive, Misleading Epstein Becker & Green, P.C.
May
24
2024
EC Scientific Committee Publishes Scientific Advice on Titanium Dioxide Bergeson & Campbell, P.C.
May
24
2024
DEA to Move to Reclassify Cannabis to Schedule III Blank Rome LLP
May
24
2024
McDermottPlus Check-Up: May 24, 2024 McDermott Will & Emery
May
24
2024
DOE Announces Additional Projects to Help Industry Address Bioenergy and Bioproduct Challenges Bergeson & Campbell, P.C.
May
24
2024
Understanding Suppliers’ Rights and Remedies in Retail and Hospitality Bankruptcies ArentFox Schiff LLP
May
23
2024
Three for Thursday - SCOTUS Today Epstein Becker & Green, P.C.
May
23
2024
California Assembly Approves Color Additive Ban in Schools Keller and Heckman LLP
May
23
2024
Pay for Delay is Sometimes Okay McDermott Will & Emery
May
23
2024
Prime Time for Prime Hydration: YouTubers Clash With PFAS Regulations ArentFox Schiff LLP
May
23
2024
Testing Negative: Collateral Order Doctrine Precludes Appellate Jurisdiction McDermott Will & Emery
May
22
2024
Recent Regulatory Actions Against Unlicensed Pharmacy Benefit Managers in West Virginia Polsinelli PC
May
22
2024
Senators Propose Heavy Metal Legislation with Product Testing Requirements Keller and Heckman LLP
May
22
2024
Proposed Marijuana Reclassification and Impact on Employers Greenberg Traurig, LLP
May
22
2024
Master of Its Choice of Forum? Foley & Lardner LLP
 

NLR Logo

We collaborate with the world's leading lawyers to deliver news tailored for you. Sign Up to receive our free e-Newsbulletins

 

Sign Up for e-NewsBulletins